立體定位腦鎖定裝置市場規模、佔有率和趨勢分析 |全球| 2026–2032年

2025年全球立體定位和穩定（STT）市場規模約為4.9億美元。預計該市場將以3.6%的複合年成長率成長，到2032年達到約6.3億美元。

本報告涵蓋全球立體定位手術器械市場，將其細分為框架式和無框架式系統，並全面分析了手術量、銷售量、平均售價、市場規模和競爭對手市場佔有率。該報告對手術量、銷量、平均售價、市場規模、成長率以及各公司的市場佔有率進行了定量分析，並包含截至2022年的歷史數據和截至2032年的預測數據。

預計在預測期內，市場將穩定成長，這主要得益於銷量增加和無框架立體定位系統的廣泛應用，後者比有框架系統價格高出不少。導航導航手術的經濟效益（例如縮短患者恢復時間和降低再次手術率）也推動了各種類型和規模的醫療機構採用這項技術。

隨著市場日趨成熟，價格壓力將會增加，平均售價預計會略為下降。然而，由於銷售量成長足以抵銷價格下降的影響，整體市場規模預計仍將繼續擴大。隨著時間的推移，成長速度預計將逐漸放緩，這反映出成熟地區的市場趨於成熟，而新興市場則推動了手術數量的成長。

市場概覽

全球立體定位和固定（STT）市場涵蓋用於在神經外科手術中精確定位腦內解剖目標的儀器和軟體系統。基於框架的STT系統使用固定在患者顱骨上的剛性框架作為參考座標系，可為深部腦目標提供最高的STT精度。無框架系統無需固定框架即可建立座標參考，而是利用表面標記、骨內植入標記或影像配準，從而提高患者舒適度和手術柔軟性。這兩種系統均廣泛應用於各種神經外科手術，包括切片檢查、電極植入、腫瘤切除和放射外科手術計劃。

預測期內市場動態的一個關鍵特徵是向無框架立體定位系統的轉變。雖然無框架系統的價格明顯高於有框架系統，但這主要是受醫師偏好和醫療機構經驗的影響，而非臨床優勢。研究表明，有框架和無框架方法在診斷準確率和併發症率方面相當，有框架系統在需要深部腦入路的手術中，其準確性仍然是公認的黃金標準。儘管臨床效果相當，且有框架系統在準確性方面更勝一籌，但出於醫生操作便捷和手術流程最佳化的考慮，許多醫療機構越來越傾向於選擇無框架系統，這推動了每套系統平均收入的成長。

術中導航的經濟效益正推動其在各類醫療機構的廣泛應用。導航導航手術可縮短患者復原時間，降低再次手術率，最終為醫療機構節省長期成本。多種導航平台配置方案，包括專用手術室、移動推車系統和筆記型電腦等，使得不同規模和資源水平的醫院都能採用這項技術，從而將潛在基本客群擴展到大型學術醫療中心之外。

隨著市場日趨成熟，預計成長速度將逐步放緩。由於成熟市場的滲透率較高，增量利潤預期較為溫和。隨著市場競爭加劇，競爭環境對平均售價（ASP）構成了一定的下行壓力。然而，銷售成長、產品組合向高價位無框系統轉變以及新興市場的擴張等因素，共同確保了市場價值在整個預測期內保持穩定的正成長。

市場促進因素

引進無框架系統

無框架立體定位系統的日益普及推動了市場成長，因為與傳統的有框架系統相比，這類系統價格較高。這一趨勢主要受醫師偏好和醫療機構經驗的影響，而非臨床證據證明無框架系統具有優越性。研究表明，兩種方法的診斷準確率和併發症率相當，有框架系統仍然是準確性的黃金標準，尤其是在需要進入深部腦部結構的手術中。然而，無框架系統的實際優勢——例如提高患者舒適度、簡化工作流程和縮短術前準備時間——使其在許多神經外科計畫中越來越受歡迎。由於無框架系統的單價較高，其市場價值的成長貢獻遠大於銷售量的成長。

經濟效益

在神經外科手術中引入立體定位導航系統，可為推廣應用該系統的醫療機構帶來顯著的經濟效益。導航導引手術能夠縮短患者復原時間，降低再次手術的可能性，從而降低單例手術的總醫療成本，並提高醫療機構的資源利用效率。目前有多種導航平台可供選擇，包括專用導航室、行動推車式系統和基於筆記型電腦的配置，使不同規模和預算的醫院都能受益於導航系統的實施。這種柔軟性將目標市場從大規模大學醫院擴展到區域醫院和手術中心，這些機構先前缺乏足夠的空間和資金來建造專用導航基礎設施。

市場限制

訓練期

每套立體定位導航系統都需要經過專門的訓練才能在臨床環境中有效使用。培訓時長取決於系統的預期用途和複雜程度。這意味著每次使用導航系統時，都必須有受過訓練的臨床醫生或導航專家在場協助。根據醫院規模、醫生排班和人員配備情況，這項要求可能會限制導航輔助手術的數量，在缺乏受過訓練的負責人時導致手術延誤，甚至使一些醫療機構猶豫是否要投資該系統。對於小規模的醫院和專業人員有限的醫療機構而言，這些培訓和負責人配備要求構成了推廣應用的重大障礙，並阻礙了市場滲透。

延長手術時間

立體定位導航系統的使用可能會延長手術總時長，給外科醫生和醫療機構帶來日程安排和經濟負擔。手術時間延長會減少每日可安排的手術數量，影響醫療機構和外科醫生的收入，因為他們的收入通常是基於手術數量而非每台手術的耗時。此外，手術時間延長也會因麻醉時間延長而增加病患風險。雖然許多現代導航系統已將渲染時間縮短至10分鐘以​​內，部分解決了這一問題，但對於手術量大、日程安排緊湊的醫療機構而言，任何額外的手術時間仍然是需要考慮的因素。在那些優先考慮手術處理效率和嚴格控制單例利潤率的環境中，這個因素可能會阻礙導航系統的應用。

目錄

調查方法

• 第一步：專案啟動與團隊組建
• 步驟二：資料系統開發與二次調查實施
• 步驟三：準備面試設計問卷
• 第四步：進行初步調查
• 第五步：調查分析：基準估計
• 第六步：市場預測與分析
• 第七步：辨識策略機遇
• 步驟 8：最終確認和市場發布
• 步驟九：客戶回饋與市場監測

全球關稅的影響

立體定位治療設備市場

• 執行摘要
  • 全球立體定位設備市場概覽
  • 競爭分析
  • 目標市場
  • 目標區域
• 介紹
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • 立體定位腦部保護固定裝置市場
  • 框架式立體定位治療設備市場
  • 無框架立體定位腦定向固定裝置市場
• 促進因素和抑制因素
  • 市場促進因素
  • 市場限制因素
• 競爭性市佔率分析

附錄

The global stereotactic device market was valued at approximately $490 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.6%, reaching approximately $630 million by 2032.

This report covers the global market for stereotactic devices, segmented into frame-based and frameless systems, and includes complete analysis of procedures, units sold, ASPs, market values, and competitor market share. The report quantifies procedure numbers, unit sales, average selling prices, market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.

The market is expected to grow steadily over the forecast period, driven by increasing unit sales and the shift toward frameless stereotactic systems, which command a significant price premium over frame-based alternatives. Economic benefits associated with navigation-guided surgery, including shorter patient recovery times and reduced revision surgery rates, are also supporting adoption across a wide range of facility types and sizes.

Average selling prices are expected to decline slightly due to pricing pressures as the market matures, but overall market value continues to rise as volume growth more than offsets these declines. Growth rates are expected to slow gradually over time, reflecting progressive market maturation in established geographies while emerging markets provide incremental procedural volume.

Market Overview

The global stereotactic device market encompasses the equipment and software systems used to precisely locate anatomical targets within the brain during neurosurgical procedures. Frame-based stereotactic systems use a rigid frame attached to the patient's skull as a reference coordinate system, providing the highest available accuracy for deep brain targeting. Frameless systems use surface fiducials, bone-implanted markers, or imaging registration to create a coordinate reference without an attached frame, offering greater patient comfort and procedural flexibility. Both system types are used across a range of neurosurgical procedures including biopsies, electrode placement, tumor resection, and radiosurgery planning.

The shift toward frameless stereotactic systems is the defining market dynamic over the forecast period. Frameless systems command a significant price premium over frame-based alternatives, driven primarily by physician preference and institutional experience rather than clinical superiority. Studies have indicated similar diagnostic yields and complication rates between frame-based and frameless approaches, and frame-based systems remain the accepted gold standard for accuracy in procedures requiring deep brain access. Despite this clinical parity or frame-based advantage in accuracy, physician comfort and procedural workflow considerations have made frameless the growing preference in many institutions, which supports higher average revenue per system.

The economic benefits of intraoperative navigation are supporting broader adoption across facility types. Navigation-guided surgery reduces patient recovery time and lowers the rate of revision procedures, delivering cost savings to facilities over the long term. The availability of navigation platforms in multiple configurations, including dedicated room installations, mobile cart-based systems, and laptop-based options, allows hospitals of varying sizes and resource levels to adopt the technology, broadening the total addressable customer base beyond major academic centers.

Growth rates are expected to slow gradually as the market matures, with high penetration in established markets moderating incremental gains. ASPs face modest downward pressure from competitive dynamics as the market becomes more contested. Despite this, the combination of volume growth, a mix shift toward higher-priced frameless systems, and expansion in developing markets supports consistent positive market value growth through the forecast period.

Market Drivers

Adoption of Frameless Systems

The increasing adoption of frameless stereotactic systems is driving market growth through the significant price premium that these systems command relative to traditional frame-based alternatives. This trend has been driven primarily by physician preference and institutional experience rather than by clinical evidence of frameless superiority. Studies have indicated similar diagnostic yields and complication rates between the two techniques, and frame-based systems continue to be regarded as the gold standard for accuracy, particularly for procedures requiring deep access to brain structures. Nonetheless, the practical advantages of frameless systems in terms of patient comfort, workflow efficiency, and reduced procedural setup time have established them as the growing preference in many neurosurgical programs. Because frameless systems carry a higher per-unit price, the ongoing mix shift toward frameless contributes disproportionately to market value growth relative to its share of unit volume.

Economic Benefits

The use of stereotactic navigation systems for neurosurgical procedures delivers measurable economic benefits for facilities that support broader adoption. Navigation-guided surgery is associated with shorter patient recovery times and a reduced likelihood of revision surgery, lowering the total cost of care per episode and improving resource utilization within the facility. The availability of multiple navigation platform formats, including dedicated navigation rooms, moveable cart-based systems, and laptop-based configurations, gives hospitals across a wide range of sizes and budgets the ability to benefit from acquiring a navigation system. This flexibility expands the addressable market beyond large academic centers to community hospitals and surgical specialty centers that previously lacked the physical space or capital budget for a dedicated navigation infrastructure.

Market Limiters

Training Period

Each stereotactic navigation system requires a dedicated training period before it can be used effectively in clinical practice, with the length of training determined by the application and complexity of the system. This means that every time a navigation system is used, a trained clinician or navigation specialist must be available to support the procedure. Depending on hospital size, physician scheduling, and staffing resources, this requirement can limit the number of navigation-assisted procedures performed, delay procedures when trained personnel are unavailable, and discourage some facilities from investing in a system in the first place. In smaller hospitals or facilities with limited specialist staff, the training and availability requirement represents a meaningful practical barrier to adoption that moderates overall market penetration.

Increased Procedure Time

The use of stereotactic navigation systems can increase the total duration of the surgical procedure, which creates scheduling and financial pressure for both surgeons and facilities. Longer procedure times reduce the number of surgeries that can be scheduled within a given day, which affects the revenue of facilities and surgeons who are reimbursed based on the number of procedures performed rather than the time each takes. Extended procedure duration is also associated with greater patient risk due to the additional time under anesthesia. Most newer navigation systems have reduced rendering times to below ten minutes, which partially addresses this concern, but any incremental time added to a procedure remains a consideration for high-volume centers managing tight surgical schedules. This factor can discourage adoption in settings where throughput is a priority and margin on each case is closely managed.

Market Coverage and Data Scope

• Quantitative coverage: Procedure numbers, market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
• Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, and technology trends shaping demand.
• Time frame: Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
• Data sources: Primary interviews with neurosurgical device industry leaders and neurosurgeons, regulatory data, hospital procurement data, import and export data, and the iData Research internal database.
• Care settings: Hospitals, academic medical centers, and neurosurgical specialty centers.

Markets Covered and Segmentation

• The stereotactic device market is analyzed across two system categories, each assessed by procedure volume, unit volume, ASP, and market value with historical and forecast data:
• Frame-Based Stereotactic Systems
• Frameless Stereotactic Systems

Competitive Analysis

Medtronic was the leader in the global stereotactic device market in 2025. The company competes through its StealthStation surgical navigation system, one of the most widely adopted intraoperative navigation platforms in neurosurgery globally. The StealthStation's established clinical track record, broad physician familiarity, and integration capabilities with imaging and surgical planning workflows have made it the reference platform in many major neurosurgical programs. Medtronic's commercial infrastructure and global distribution network reinforce its market leadership across both frame-based and frameless navigation applications.

Brainlab held the second-leading position in the stereotactic device market in 2025. The company offers the iPlan RT system for advanced stereotactic planning, a software platform designed for both daily clinical use and advanced clinical research applications. Brainlab's strength in treatment planning software and its ability to integrate stereotactic planning with radiosurgery and radiation therapy workflows distinguishes its offering from hardware-centric navigation platforms and supports its position in academic and research-oriented neurosurgical programs.

Stryker was the third-leading competitor in the stereotactic device market in 2025. The company offers the CranialMask Tracker, used in combination with its CranialMap software to incorporate image-guided navigation into neurosurgical procedures. This system provides cranial navigation capability that integrates with Stryker's broader neurosurgical instrument and capital equipment portfolio, allowing the company to offer navigation as part of a broader procedural solution for neurosurgical customers.

Technology and Practice Trends

• Frameless system adoption: Physician preference and workflow advantages continue to drive the adoption of frameless navigation over frame-based alternatives, with the associated price premium contributing disproportionately to market value growth relative to unit share.
• Rendering time reduction: Most newer navigation systems have reduced image rendering time to below ten minutes, addressing one of the primary scheduling and workflow concerns that limited adoption in high-throughput surgical environments.
• Frame-based accuracy standard: Despite the growth of frameless systems, frame-based stereotactic approaches retain their position as the gold standard for accuracy in procedures requiring precise targeting of deep brain structures.
• Multi-platform navigation formats: The availability of dedicated room installations, mobile cart-based systems, and laptop-based navigation options is expanding the addressable customer base to facilities of varying sizes and infrastructure levels.
• Software integration: Navigation planning software integrated with imaging systems and treatment planning tools, such as the Brainlab iPlan RT platform, is enabling more sophisticated preoperative planning and intraoperative guidance across clinical and research settings.
• Expanding surgical applications: Stereotactic navigation is being applied to a growing range of neurosurgical indications beyond traditional biopsy and electrode placement, broadening the procedural base for navigation system use across centers with varying case mixes.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• Where are the largest and fastest-growing opportunities within the global stereotactic device market across frame-based and frameless system categories through 2032?
• How is the shift toward frameless stereotactic systems influencing market value growth, even where frame-based systems retain clinical accuracy advantages for deep brain procedures?
• What economic benefits do navigation systems deliver for facilities and patients, and how is multi-platform format availability expanding adoption beyond major academic centers?
• How are training requirements and procedure time increases limiting adoption in smaller facilities and high-throughput surgical environments?
• Which companies lead the market and how are their navigation hardware and software platforms differentiated across frame-based, frameless, and planning software categories?
• How is software integration between stereotactic planning platforms and imaging or radiosurgery systems shaping the competitive landscape and purchasing decisions?
• What is the outlook for ASP trends as the market matures and pricing competition intensifies, and how does the frameless-to-frame-based mix shift affect overall revenue per system?
• What are the key risks to market growth, including pricing pressure, staffing and training constraints, procedure time concerns, and the pace of adoption in emerging markets?

The Global Stereotactic Device Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail. Use it to quantify demand, benchmark competitors, and plan commercial strategy across a steadily growing market defined by a physician-driven shift toward premium frameless systems and expanding facility adoption.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Stereotactic Device Market

• 15.1 Executive Summary
  • 15.1.1 Global Stereotactic Market Overview
  • 15.1.2 Competitive Analysis
  • 15.1.3 Markets Included
  • 15.1.4 Regions Included
• 15.2 Introduction
• 15.3 Market Overview
  • 15.3.1 By Segment
  • 15.3.2 By Region
• 15.4 Market Analysis And Forecast
  • 15.4.1 Total Stereotactic Device Market
  • 15.4.2 Frame-Based Stereotactic Device Market
  • 15.4.3 Frameless Stereotactic Device Market
• 15.5 Drivers And Limiters
  • 15.5.1 Market Drivers
  • 15.5.2 Market Limiters
• 15.6 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

• Chart 15-1: Stereotactic Device Market, Global, 2025 & 2032
• Chart 15-2: Stereotactic Units, Global, 2025
• Chart 15-3: Stereotactic Device Market by Segment, Global, 2022 - 2032
• Chart 15-4: Stereotactic Device Market by Region, Global, 2022 - 2032
• Chart 15-5: Leading Competitors, Stereotactic Market, Global, 2025

LIST OF FIGURES

• Figure 15-1: Stereotactic Device Markets Covered
• Figure 15-2: Stereotactic Regions Covered, Global (1 of 2)
• Figure 15-3: Stereotactic Regions Covered, Global (2 of 2)
• Figure 15-4: Stereotactic Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 15-5: Stereotactic Device Market by Region, Global, 2022 - 2032 (US$M)
• Figure 15-6: Total Stereotactic Device Market, Global, 2022 - 2032
• Figure 15-7: Units Sold by Region, Stereotactic Device Market, Global, 2022 - 2032
• Figure 15-8: Average Selling Price by Region, Stereotactic Device Market, Global, 2022 - 2032 (US$)
• Figure 15-9: Market Value by Region, Stereotactic Device Market, Global, 2022 - 2032 (US$M)
• Figure 15-10: Frame-Based Stereotactic Device Market, Global, 2022 - 2032
• Figure 15-11: Units Sold by Region, Frame-Based Stereotactic Device Market, Global, 2022 - 2032
• Figure 15-12: Average Selling Price by Region, Frame-Based Stereotactic Device Market, Global, 2022 - 2032 (US$)
• Figure 15-13: Market Value by Region, Frame-Based Stereotactic Device Market, Global, 2022 - 2032 (US$M)
• Figure 15-14: Frameless Stereotactic Device Market, Global, 2022 - 2032
• Figure 15-15: Units Sold by Region, Frameless Stereotactic Device Market, Global, 2022 - 2032
• Figure 15-16: Average Selling Price by Region, Frameless Stereotactic Device Market, Global, 2022 - 2032 (US$)
• Figure 15-17: Market Value by Region, Frameless Stereotactic Device Market, Global, 2022 - 2032 (US$M)
• Figure 15-18: Leading Competitors, Stereotactic Market, Global, 2025